| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 693.94 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This report presents a quantitative analysis of Philips, focusing on
its valuation through a detailed examination of historical financial
data and projections of future performance. It analyzes Philips'
departments - Diagnostics and Treatment, Connected Care, and
Personal Health - to forecast growth and challenges. The report
employs the Damodaran method for optimal debt level calculation
and includes a macroeconomic risk assessment, emphasizing the
impact of ongoing litigation on Philips' valuation. Concluding
with a transparent explanation of the assumptions in the
Discounted Cash Flow (DCF) analysis and multiples, it provides
a positive share price recommendation for Philips of 26.41 Euro.
Descrição
Palavras-chave
Philips Koninklijke philips n.v. Healthcare Connected care Diagnostics and imaging Personal health Aex Valuation Dcf Apv Multiples Litigation Forecasts
